Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71.4M
-
Number of holders
-
78
-
Total 13F shares, excl. options
-
28.4M
-
Shares change
-
+2.92M
-
Total reported value, excl. options
-
$559M
-
Value change
-
+$47.8M
-
Number of buys
-
46
-
Number of sells
-
-29
-
Price
-
$19.67
Significant Holders of Phathom Pharmaceuticals, Inc. - Common Stock (PHAT) as of Q4 2021
95 filings reported holding PHAT - Phathom Pharmaceuticals, Inc. - Common Stock as of Q4 2021.
Phathom Pharmaceuticals, Inc. - Common Stock (PHAT) has 78 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.4M shares
of 71.4M outstanding shares and own 39.83% of the company stock.
Largest 10 shareholders include FRAZIER MANAGEMENT LLC (5.83M shares), RA CAPITAL MANAGEMENT, L.P. (3.12M shares), Medicxi Ventures Management (Jersey) Ltd (2.07M shares), Invesco Ltd. (2.07M shares), VANGUARD GROUP INC (1.93M shares), Avidity Partners Management LP (1.9M shares), JANUS HENDERSON GROUP PLC (1.84M shares), BlackRock Inc. (1.47M shares), Ensign Peak Advisors, Inc (1.32M shares), and Abingworth LLP (1.2M shares).
This table shows the top 78 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.